In an in vitro study, it was demonstrated that treatment with parvovirus could sensitize p53-negative HCC cells to the cytotoxic effects of cisplatin, and combination therapy resulted in increased HCC cell death in comparison to either individual therapy (70). This evidence concerns the gene TP53 and hepatocellular carcinoma.